Xuchao Zhang Selected Research

Stomach Neoplasms (Stomach Cancer)

1/2020	Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth.
1/2019	Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuchao Zhang Research Topics

Disease

22	Neoplasms (Cancer) 10/2023 - 01/2010
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2009
5	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2010
4	Neoplasm Metastasis (Metastasis) 10/2023 - 11/2016
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
3	Adenocarcinoma of Lung 01/2020 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2010
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 02/2015
2	Asthma (Bronchial Asthma) 03/2014 - 02/2011
2	Lymphoma (Lymphomas) 01/2012 - 07/2010
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Disease Progression 01/2020
1	Adenocarcinoma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Mesothelioma 01/2019
1	Neoplasm Micrometastasis 01/2016
1	Esophageal Neoplasms (Esophageal Cancer) 01/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2012
1	Inflammation (Inflammations) 02/2011
1	Nasopharyngeal Carcinoma 01/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2010

Drug/Important Bio-Agent (IBA)

8	ErbB Receptors (EGF Receptor)IBA 04/2019 - 07/2009
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2009
4	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2017
4	Tyrosine Kinase InhibitorsIBA 12/2017 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 05/2015 - 07/2009
2	CytokinesIBA 01/2020 - 01/2019
2	MesothelinIBA 01/2020 - 01/2019
2	Gefitinib (Iressa)FDA Link 04/2019 - 01/2017
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 07/2010
2	MicroRNAs (MicroRNA)IBA 02/2015 - 01/2013
2	OzoneIBA 03/2014 - 02/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 09/2010
2	Messenger RNA (mRNA)IBA 07/2010 - 01/2010
1	Sucrose (Saccharose)IBA 10/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	ChemokinesIBA 01/2021
1	anlotinibIBA 01/2021
1	Coloring Agents (Dyes)IBA 10/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2020
1	sintilimabIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 02/2019
1	Granzymes (Granzyme)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	AntibodiesIBA 11/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	AntigensIBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2016
1	Conditioned Culture MediaIBA 03/2014
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2012
1	Cysteine (L-Cysteine)FDA Link 01/2012
1	130-nm albumin-bound paclitaxelIBA 01/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	Caveolin 1IBA 01/2012
1	Docetaxel (Taxotere)FDA Link 09/2011
1	Sunitinib (Sutent)FDA Link 09/2011
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2011
1	GenisteinIBA 01/2010

Therapy/Procedure

8	Therapeutics 01/2023 - 07/2009
4	Immunotherapy 01/2020 - 01/2017
3	Neoadjuvant Therapy 01/2021 - 05/2015
2	Lasers (Laser) 01/2021 - 04/2019
1	Drug Therapy (Chemotherapy) 01/2020
1	Radiotherapy 01/2020
1	Precision Medicine 02/2019
1	Aftercare (After-Treatment) 01/2012